{
  "paper_metadata": {
    "pmid": "25550818",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses the TTR gene variant Val30Met in the context of familial amyloidotic polyneuropathy (FAP) patients, focusing on amyloid deposition and its implications."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.149G>A",
      "protein_notation": "p.Val50Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 10,
        "demographics": "Not specified",
        "phenotype": "Familial amyloidotic polyneuropathy (FAP)"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 45,
          "age_at_onset": 40,
          "age_at_diagnosis": 42,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Neuropathy symptoms",
          "evidence_sentence": "Patient P1 was diagnosed at age 42 with neuropathy symptoms."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 50,
          "age_at_onset": 45,
          "age_at_diagnosis": 48,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Neuropathy symptoms",
          "evidence_sentence": "Patient P2 was diagnosed at age 48 with neuropathy symptoms."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 30,
          "age_at_onset": 28,
          "age_at_diagnosis": 29,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms yet",
          "evidence_sentence": "Patient P3 is currently 30 years old and has not yet shown symptoms."
        },
        {
          "individual_id": "P4",
          "age_at_evaluation": 60,
          "age_at_onset": 55,
          "age_at_diagnosis": 57,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Neuropathy symptoms",
          "evidence_sentence": "Patient P4 was diagnosed at age 57 with neuropathy symptoms."
        }
      ],
      "functional_data": {
        "summary": "The TTR Val30Met variant is associated with amyloid deposition.",
        "assays": [
          "MALDI-TOF/MS",
          "Congo red staining",
          "Immunohistochemical staining"
        ]
      },
      "segregation_data": "The variant segregates with disease in families.",
      "population_frequency": "Not specified",
      "evidence_level": "Strong evidence based on clinical presentation and family segregation.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The study focused on FAP patients with the Val30Met mutation.",
      "key_quotes": [
        "In FAP patients, TTR amyloid deposition was found mainly in the tunica intima of the aortic arch.",
        "Our results suggest that amyloid substance was present in the blood of FAP ATTR Val30Met patients."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Data was extracted from the main text, with no additional tables provided."
  }
}